Let’s break it down:
- Company is allowed to mention “injectable migraine treatment,” since they’re NOT the only ones who’d fall under this category (Botox also treats migraines—although chronic—and is an injection)
- If Zembrace was the sole “injectable migraine treatment,” this ad would not be following regulations and would be considered branded by the OPDP
How can this ad be improved?
- “Click here” [and even “learn more”] isn’t a strong call to action and not recommended by the usability experts; therefore ad could be improved by stating exactly what visitors will learn about on the landing page
- There’s no compelling reason to click on the ad, especially considering that many patients might be scared of the injectables. Perhaps, supplement with an offer: “Can injectable migraine treatment be right for you? [Start your assessment >]”
Refresh your knowledge: see our digital pharma banner ads cheat sheet.